Adult-to-adult living donor liver transplantation for acute liver failure in China

Table 4 The characteristics of living donors

Parameters	Donors (n = 23)
Preoperative
Age (yr)	37.7 ± 10.2
Gender (male/female)	8/15
BMI (kg/m2)	23.8 ± 3.5
Relationship with recipient (n)
Siblings	12
Daughter	4
Wives	5
Father	1
Uncle	1
Assessment time (d)	2.1 ± 1.3
Intraoperative
Graft steatosis (normal/mild)	18/5
Graft type (right lobe/left lobe)	20/3
RLV/TLV (%)	56.5 ± 12.1
Operation time (h)	6.9 ± 1.4
Blood lost (mL)	665.2 ± 480.9
Postoperative
Hospital stay (d)	13.4 ± 3.5
Peak of TB (μmol/L)	53.4 ± 22.7
Peak of INR	1.71 ± 0.36
Complications (n)	11
GradeI(n = 7)
Pleural effusion (mild)	4
Hepatic function impairment (mild)	2
Hepatic cut-section local fluid collection	1
Grade II (n = 3)
Pleural effusion (moderate) leading to partial compression atelectasis and hepatic function impairment (mild)	1
Pleural effusion (moderate) and pericardial effusion	1
Pulmonary infection undergone antibiotic therapy and hepatic function impairment (moderate)	1
Grade IIIa (n = 1)
Pleural effusion (server) using pleurocentesis	1

Hepatic function impairment: Mild, hyperbilirubinemia (TB being 51-85 μmol/L for more than 3 d or 34-51 μmol/L on POD7) and/or PT prolongation (6-8 s for more than 3 d or 4-6 s on POD7); Moderate, hyperbilirubinemia (TB > 85 μmol/L for more than 3 d or exceeding 51 μmol/L on POD7) and/or PT prolongation (> 8 s for more than 3 d or exceeding 6 s on POD7). BMI: Body mass index; RLV: Remanet live volume; TLV: Total liver volume; TB: Total bilirubin; INR: International normalized ratio; PT: Prothrombin time.